BCBA/PFED (BCBA/PFED)

Buenos Aires Stock Exchange: BCBA/PFED · USD

$7.86

-0.05 (-0.6%)· Recorded snapshot

Market cap	261.3T
Revenue (ttm)	93.9T
Net income (ttm)	6.4T
EPS (ttm)	$292
P/E (trailing)	41.4x
P/E (forward)	10.4x
Dividend	$484 (4.01%)
Volume	5,349

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 93.9T
Net income (ttm): 6.4T
EPS (ttm): $292
P/E (trailing): 41.4x
P/E (forward): 10.4x
Market cap: 261.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.4

P25 n/aP50 n/aP75 n/a

Trailing P/E41.4

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC13.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/PFED indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-03
Employees	75,000
Employees change	-6,000
Employees growth	-7.41%
Enterprise value	$341.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-10-10
Fiscal year end	December
Founded	1849
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT111424
Last refreshed	2026-10-28
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	$261.3T
Next earnings date	2026-11-03
Price	$7.86
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/PFED
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.97x
Average P/E ratio (3Y)	26.74x
Average P/E ratio (5Y)	19.53x
Earnings yield	2.42%
EV/Earnings	53.43x
EV/EBIT	11.78x
EV/EBITDA	8.44x
EV/FCF	21.08x
EV/Sales	3.48x
FCF / EV yield	4.74%
FCF yield	6.2%
Forward P/E	10.42x
Graham number	4.07523
Graham upside	-48.48%
Lynch fair value	$0.97
Lynch upside	-87.77%
P/(FCF - SBC) ratio	17.66x
P/(OCF - SBC) ratio	14.23x
P/B ratio	2.07x
P/E ratio	41.38x
P/FCF ratio	16.13x
P/OCF ratio	13.22x
P/S ratio	2.78x
Price/EBITDA ratio	6.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.58%
EBITDA margin	39.85%
FCF margin	16.53%
Gross margin	74.72%
Operating margin	29.58%
Pretax margin	6.61%
Profit margin	6.8%
Profit per employee	$85.2M
Profitable years	35
Revenue per employee	$1.3B
ROA	5.78%
ROA (5Y)	7.03%
ROCE	11.18%
ROE	5.01%
ROE (5Y)	17.68%
ROIC	13.49%
ROIC (5Y)	18.62%
SBC / revenue	1.49%
Tax / revenue	-0.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-59.88%
EPS growth 10Y	-3.88%
EPS growth 3Y	-41.3%
EPS growth 5Y	-19.56%
EPS growth years	0
FCF growth	-11.68%
FCF growth (QoQ)	-86.14%
FCF growth 3Y	0.99%
FCF growth 5Y	-12.27%
Gross profit growth	2.68%
Gross profit growth (Q)	2.04%
Gross profit growth 3Y	-4.76%
Gross profit growth 5Y	3.85%
Net income growth	-59.69%
Net income growth 3Y	-41.34%
Net income growth 5Y	-19.42%
Net income growth years	0
OCF growth	-11.77%
OCF growth (QoQ)	-68.07%
OCF growth 10Y	-1.34%
OCF growth 3Y	-2.73%
OCF growth 5Y	-10.66%
Operating income growth	11.09%
Operating income growth (Q)	-0.31%
Operating income growth 3Y	-10.2%
Operating income growth 5Y	5.06%
Revenue growth	-0.21%
Revenue growth (Q)	2.6%
Revenue growth (QoQ)	4.03%
Revenue growth 10Y	1.99%
Revenue growth 3Y	-6.7%
Revenue growth 5Y	2.93%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.6T
Depreciation and amortization	$10.1T
EBIT	$27.8T
EBITDA	$37.4T
EPS	$292.22
Financing cash flow	$-12.4T
Free cash flow	$16.2T
Free cash flow minus SBC	$14.8T
Gross profit	$70.2T
Income taxes	$-241.8B
Investing cash flow	$-8.4T
Net borrowing	$2.7T
Net cash flow	$-973B
Net income	$6.4T
Operating cash flow minus SBC	$18.4T
Operating income	$27.8T
Revenue	$93.9T
Stock-based compensation	$1.4T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.22
Book value per share	$22,036.69
Debt / EBITDA	2.41
Debt / equity	0.74
Debt / FCF	5.78
Goodwill	$109.9T
Interest coverage	6.98
Long-term assets	$232.9T
Long-term liabilities	$120.3T
Net cash (debt)	$-76.3T
Net cash / market cap	-29.22%
Net debt / EBITDA	2.04
Net debt / equity	0.61
Net debt / FCF	4.71
Piotroski F-Score	7
Property, plant and equipment	$29.3T
Shareholders' equity	$126T
Tangible book value	$-49.1T
Tangible book value per share	$-8,609.29
Total assets	$296.5T
Total cash	$17.3T
Total debt	$93.6T
Total liabilities	$170.5T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	$63.6T
Current liabilities	$50.2T
Current ratio	1.27
Inventory turnover	1.49
Net working capital	$-418.7B
Quick ratio	0.85
Working capital	$12.8T
Working capital turnover	12,785.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.34%
Dividend growth	13.51%
Dividend growth (3Y)	6.22%
Dividend growth (5Y)	-7.99%
Dividend growth years	3
Dividend payment date	2026-12-07
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$484.50
Dividend yield	4.01%
Ex-dividend date	2026-11-06
Last dividend	$0.11
Payout ratio	225.77%
Shareholder yield	3.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$6.95
1D price change	-0.63%
1M price change	6.46%
1M total return	6.46%
1W price change	-0.5%
1W total return	-0.5%
1Y price change	25.96%
1Y return CAGR	31.45%
1Y total return	31.42%
20-day SMA	$7.59
200-day SMA	$6.92
3M price change	23.59%
3M total return	23.59%
3Y price change	-2.94%
3Y return CAGR	3.06%
3Y total return	9.47%
50-day SMA	$7.41
50-day SMA vs 200-day SMA	50over200
52-week high	$8.07
52-week high date	2026-10-26
52-week low	$6.00
52-week low date	2025-11-05
6M price change	12.84%
6M total return	15.22%
All-time high	$14.55
All-time high date	2022-01-28
All-time low	$5.18
All-time low date	2025-04-09
Average true range (ATR)	$0.19
Average volume	4.8K
Change from 52-week high	-2.6%
Change from 52-week low	31%
Change from all-time high	-45.64%
Change from all-time low	52.7%
Change from open	-1.13%
Day's gap	0.51%
Dollar volume	$42,043
High price	$7.96
Low price	$7.83
Monthly RSI	57.34
Open price	$7.95
Position in 52-week range	23.08%
Previous close	$7.91
Price vs 150-day SMA	13.81%
Price vs 20-day SMA	4.23%
Price vs 200-day SMA	14.34%
Price vs 50-day SMA	6.78%
Relative volume	1.12
RSI	61.24
Sharpe ratio	1.1
Sharpe ratio (3Y)	0.05
Sortino ratio	1.89
Sortino ratio (3Y)	0.23
Volume	5.3K
Weekly RSI	67.33
YTD price change	23.21%
YTD total return	27.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.7B
Shares change (QoQ)	-0.56%
Shares change (YoY)	0.34%
Shares held by insiders	0.03%
Shares held by institutions	68.07%
Short ratio	4 days

Deeper analysis on BCBA/PFED

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/PFED report

Is a complete BCBA/PFED research report available?

No complete published report is available for bcba/PFED (BCBA/PFED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/PFED (BCBA/PFED)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/PFED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/PFED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/PFED

Frequently asked questions